logo
  • Home
  • News
Menu

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

Home / Stock Analysis / GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A
Article feature image

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

12 Aug Stock Analysis

YONGIN, South Korea–(BUSINESS WIRE)–GC Pharma (006280.KS) today announced the approval of GreenGene F (Beroctocog alfa)

Click here to view the original article.

Tags:
Business Wire, Global
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

1585186599552.jpeg
+

Is Praxis Precision Medicines (PRAX) Price Missing The Story After A 326% One-Year Surge?

14 Jan Stock Analysis
1585187584767.jpeg
+

Is Deckers Outdoor (DECK) Pricing Reflect Its Recent 50% Share Price Slide

14 Jan Stock Analysis

recent post

  • brian-armstrong-coinbase-decrypt-style-2-gID_7.png

    Coinbase Withdraws Support for Crypto Bill

    Jan 14 2026
  • 1585186599552.jpeg

    Is Praxis Precision Medicines (PRAX) Price

    Jan 14 2026
  • 1768428957_0x0.jpg

    How Maduro’s Detention Could Reshape Crypto

    Jan 14 2026
  • 1585187584767.jpeg

    Is Deckers Outdoor (DECK) Pricing Reflect

    Jan 14 2026
  • Russia Wants To Make Crypto ‘Everyday

    Jan 14 2026

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.